Corticosteroid therapy for liver abscess in chronic granulomatous disease

Clinical Infectious Diseases

Volumn 54, Issue 5, 2012, Pages 694-700

  Leiding, Jennifer W ^a   Freeman, Alexandra F ^a   Marciano, Beatriz E ^a   Anderson, Victoria L ^a   Uzel, Gulbu ^a   Malech, Harry L ^b   Deravin, Suksee ^b   Wilks, David ^c   Venkatesan, Aradhana M ^d   Zerbe, Christa S ^a   Heller, Theo ^e   Holland, Steven M ^a  

^a Laboratory of Clinical Infectious Diseases   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d Clinical Center   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CEFADROXIL; FLUCLOXACILLIN; FLUCONAZOLE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; METHYLPREDNISOLONE; METICILLIN; OXACILLIN; PREDNISONE; RIFAMPICIN; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASPERGILLOSIS; BILIRUBIN BLOOD LEVEL; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FILIPINO; HUMAN; LIVER CONGESTION; LIVER FUNCTION TEST; LIVER SURGERY; LIVER VEIN OBSTRUCTION; LYMPHADENITIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PRIORITY JOURNAL; PYOGENIC LIVER ABSCESS; STAPHYLOCOCCUS AUREUS; X CHROMOSOME LINKED DISORDER;

ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LIVER ABSCESS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856913573     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir896     Document Type: Article

References (28)

1. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363:2600-10.
2. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79:170-200.
3. Lublin M, Bartlett DL, Danforth DN, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg 2002; 235:383-91.
4. Chin TW, Stiehm ER, Falloon J, Gallin JI. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr 1987; 111:349-52.
5. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114:462-8.
6. Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol 2009; 104:117-24.
7. Moltyaner Y, Geerts WH, Chamberlain DW, et al. Underlying chronic granulomatous disease in a patient with bronchocentric granulomatosis. Thorax 2003; 58:1096-8.
8. Narita M, Shibata M, Togashi T, Tomizawa K, Matsumoto S. Steroid therapy for bronchopneumonia in chronic granulomatous disease. Acta Paediatr Jpn 1991; 33:181-5.
9. Okano M, Yamada M, Ohtsu M, et al. Successful treatment with methylprednisolone pulse therapy for a life-threatening pulmonary insufficiency in a patient with chronic granulomatous disease following pulmonary invasive aspergillosis and Burkholderia cepacia infection. Respiration 1999; 66:551-4.
10. Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, Hernandez-Bautista V, Espinosa-Rosales F. Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol 2006; 97:257-61.
11. Siddiqui S, Anderson VL, Hilligoss DM, et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 2007; 45:673-81.
12. Feld JJ, Hussain N, Wright EC, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008; 134:1917-26.
13. Hussain N, Feld JJ, Kleiner DE, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007; 45:675-83.
14. Johnston RB, Newman SL. Chronic granulomatous disease. Pediatr Clin North Am 1977; 24:365-76.
15. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185:207-18.
16. Kobayashi SD, Voyich JM, Braughton KR, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 2004; 172:636-43.
17. Bylund J, MacDonald KL, Brown KL, et al. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROSindependent activation of NF-kappaB. Eur J Immunol 2007; 37:1087-96.
18. Brown KL, Bylund J,MacDonald KL, et al. ROS-deficientmonocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol 2008; 129:90-102.
19. Segal BH, Kuhns DB, Ding L, Gallin JI, Holland SM. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation. J Leukoc Biol 2002; 71:410-16.
20. Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI. Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J Immunol 2005; 174:411-17.
21. Segal BH, Han W, Bushey JJ, et al. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 2010; 5:e9631.
22. Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451:211-15.
23. De Ravin SS, Zarember KA, Long-Priel D, et al. Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease. Blood 2010; 116:1755-60.
24. Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, Bratton DL. PPARgamma activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease. Blood 2010; 116:4512-22.
25. Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011; 163:29-43.
26. Girard M, Lacasse Y, Cormier Y. Hypersensitivity pneumonitis. Allergy 2009; 64:322-34.
27. Freeman AF,Marciano BE, Anderson VL, Uzel G, Costas C, Holland SM. Corticosteroids in the treatment of severe Nocardia pneumonia in chronic granulomatous disease. Pediatr Infect Dis J 2011; 30:806-8.
28. Kontras SB, Bodenbender JG, McClave CR, Smith JP. Interstitial cystitis in chronic granulomatous disease. J Urol 1971; 105:575-8.